avutometinib
verastem oncology
['ovarian', 'avutometinib']
in a session at 4:30pm, &amp; andrew clamp share the initial efficacy &amp; safety results of avutometinib from a phase 2 study on #ovariancancer: #crukfunded #asco23 
We're here to support our broad cancer research community of 4,000 scientists and clinicians. For general Cancer Research UK news & fundraising follow @CR_UK